Project Details
Projekt Print View

Treatment of type 1 diabetes with porcine islet cells: transplantation of multi-transgenic islets expressing immunomodulatory molecules (C03)

Subject Area Endocrinology, Diabetology, Metabolism
Immunology
Term since 2012
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 213602983
 
We have shown that immune rejection against porcine islets is significantly reduced by overexpression of immunomodulatory molecules targeting co-stimulatory and co-inhibitory receptors/ligands. The present project focuses on the identification of specific knockout and transgene combinations that establish long-lasting immune tolerance in combination with a clinically applicable minimised immunosuppression. Furthermore, transplantation experiments with novel innovative immunosuppressive drugs will be performed in relevant preclinical animal models. The results of these studies will be crucial for the development of a protocol for the first clinical pilot trial on free porcine islet transplantation in patients with type 1 diabetes.
DFG Programme CRC/Transregios
 
 

Additional Information

Textvergrößerung und Kontrastanpassung